Pulmonx Corporation LUNG Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Pulmonx Corporation’s reported figures.
Based on trailing twelve months.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's return on equity?
- Pulmonx Corporation (LUNG) reported return on equity of -86.2% in Q1 2026.
- How has Pulmonx Corporation's return on equity changed year-over-year?
- Pulmonx Corporation's return on equity decreased by 42.1% year-over-year, from -60.7% to -86.2%.
- What is the long-term trend for Pulmonx Corporation's return on equity?
- Over 4 years (2021 to 2025), Pulmonx Corporation's return on equity has grown at a 35.0% compound annual growth rate (CAGR), from -23.2% to -77.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.